Abstract
The randomized clinical trial (RCT) is a research design used to compare two or more forms of therapy. Four traits that distinguish an RCT from routine clinical care are (1) an RCT is controlled (all subjects in the RCT are selected based upon stringent predetermined entrance criteria), (2) it is randomized (subjects are assigned to treatment groups by chance, independent of their individual characteristics), (3) the final outcome is established through statistical analysis (criteria are established for measuring differences among the two groups prior to initiation of the study, and the data are analysed to determine of the preset level of significance is obtained), (4) most often, a double-blind technique is employed.
References
Abaid LN, Grimes DA, Schulz KF. Reducing publication bias of prospective clinical trials through trial registration. Contraception. 2007;76(5):339–41.
Al-Namankany AA, Ashley P, Moles DR, et al. Assessment of the quality of reporting of randomized clinical trials in paediatric dentistry journals. Int J Paediatr Dent. 2009;19:318–24.
Altman DG. Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors. BMJ. 2005;330(7499):1056–7.
Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al.; CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663–94.
Altman DG. Statistics and ethics in medical research: III How large a sample? Br Med J. 1980;281(6251):1336–8.
Antczak AA, Tang J, Chalmers TC. Quality assessment of randomized controlled trials in dental research. II. Results: periodontal research. J Periodontal Res. 1986;21:315–21.
Bahrami M, Deery C, Clarkson JE, Pitts NB, Johnston M, Rickettes I, et al. Effectiveness of strategies to disseminate and implement clinical guidelines for the management of impacted and unerupted third molars in primary dental care, a cluster randomized controlled trial. Br Dent J. 2004;197:691–6.
Bailar 3rd JC, Mosteller F. Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations. Ann Intern Med. 1988;108:266–73.
Bang H, Ni L, Davis C E. Assessment of blinding in clinical trials. Controlled Clinical Trials. 2004;25:143–156.
Barbui C, Cipriani A, Malvini L, et al. Validity of the impact factor of journals as a measure of randomized controlled trial quality. J Clin Psychiatry. 2006; 67:37–40.
Bassler D, Ferreira-Gonzalez I, Briel M, Cook DJ, Devereaux PJ, Heels-Ansdell D, Kirpalani H, Meade MO, Montori VM, Rozenberg A, Schünemann HJ, Guyatt GH. Systematic reviewers neglect bias that results from trials stopped early for benefit. J Clin Epidemiol. 2007;60:869–73.
Bassler D, Montori VM, Briel M, Glasziou P, Guyatt G. Early stopping of randomized clinical trials for overt efficacy is problematic. J Clin Epidemiol. 2008;61:241–6.
Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH; STOPIT-2 Study Group, Flynn DN, Elamin MB, Murad MH, Abu Elnour NO, Lampropulos JF, Sood A, Mullan RJ, Erwin PJ, Bankhead CR, Perera R, Ruiz Culebro C, You JJ, Mulla SM, Kaur J, Nerenberg KA, Schünemann H, Cook DJ, Lutz K, Ribic CM, Vale N, Malaga G, Akl EA, Ferreira-Gonzalez I, Alonso-Coello P, Urrutia G, Kunz R, Bucher HC, Nordmann AJ, Raatz H, da Silva SA, Tuche F, Strahm B, Djulbegovic B, Adhikari NK, Mills EJ, Gwadry-Sridhar F, Kirpalani H, Soares HP, Karanicolas PJ, Burns KE, Vandvik PO, Coto-Yglesias F, Chrispim PP, Ramsay T. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA. 2010;303:1180–7.
Beller EM, Gebski V, Keech AC. Randomisation in clinical trials. Med J Aust. 2002;177:565–7.
Blinkhorn AS, Gratrix D, Holloway PJ, Wainwright-Stringer YM. A cluster randomised, controlled trial of the value of dental health educators in general dental practice. Br Dent J. 2003;195:395–400.
Boutron I, Ravaud P. Improving the reporting of clinical research. Br J Surg. 2009;96:449–50.
Boutron I, Estellat C, Ravaud P. A review of blinding in randomized controlled trials found results inconsistent and questionable. J Clin Epidemiol. 2005;58:1220–6.
Boutron I, Estellat C, Guittet L, Dechartres A, Sackett DL, Hrobjartsson A, et al. Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review. PLoS Med. 2006;3:e425.
Boutron I, Guittet L, Estellat C, Moher D, Hrobjartsson A, Ravaud P. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Med. 2007;4:e61.
Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148(4):295–309.
Burns DR, Elswick RK. Equivalence testing with dental clinical trials. J Dent Res. 2001;80:1513–7.
Cakir B, Gebski VJ, Keech AC. Flow of participants in randomised studies. Med J Aust. 2003;178:347–9.
Campbell MK, Elbourne DR, Altman DG, CONSORT Group. CONSORT statement: extension to cluster randomised trials. BMJ. 2004;328(7441):702–8.
Carpenter Jr WT, Appelbaum PS, Levine RJ. The Declaration of Helsinki and clinical trials: a focus on placebo-controlled trials in schizophrenia. Am J Psychiatry. 2003;160:356–62.
Chalmers TC. Letters to the editor. When should randomization begin? Lancet. 1968;1:858.
Chatellier G, Zapletal E, Lemaitre D, Menard J, Degoulet P. The number needed to treat: a clinically useful nomogram in its proper context. BMJ. 1996; 312(7028):426–9.
Christensen E. Methodology of superiority vs. equivalence trials and non-inferiority trials. J Hepatol. 2007;46:947–54.
Cioffi I, Farella M. Quality of randomised controlled trials in dentistry. Int Dent J. 2011;61:37–42.
ClinicalTrials.gov. http://www.clinicaltrials.gov. Accessed 11 May 2011.
Colditz GA, Miller JN, Mosteller F. How study design affects outcomes in comparisons of therapy. I: Medical Stat Med. 1989;8:441–54.
Committee for Proprietary Medicinal Products (CPMP). Points to consider on switching between superiority and non-inferiority. Br J Clin Pharmacol. 2001;52:223–8.
Cooley WE, Castellion AW. International regulatory aspects of clinical periodontal research. Ann Periodontol. 1997;2:18–30.
Current Controlled Clinical Trials. http://www.controlled-trials.com/. Accessed 11 May 2011.
De Angelis C, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med. 2004a;351:1250–1.
De Angelis C, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet. 2004b;364:911–2.
De Angelis CD, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA. 2004c;292:1363–4.
Dennison DK. Components of a randomized clinical trial. J Periodontal Res. 1997;32:430–8.
Devereaux PJ, Manns BJ, Ghali WA, Quan H, Guyatt GH. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA. 2001;285:2000–3.
Devereaux PJ, Manns BJ, Ghali WA, Quan H, Guyatt GH. The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials. 2002;23:380–8.
Doig GS, Simpson F. Randomization and allocation concealment: a practical guide for researchers. J Crit Care. 2005;20:187–91.
Duke SP, Garrett S. Equivalence in periodontal trials: a description for the clinician. J Periodontol. 1998; 69:650–4.
Dumbrigue HB, Al-Bayat MI, Ng CC, et al. Assessment of bias in methodology for randomized controlled trials published on implant dentistry. J Prosthodont. 2006;15:257–63.
Endacott R, Botti M. Clinical research 3: Sample selection. Accid Emerg Nurs. 2007;15(4):234–8.
Egger M, Jüni P, Bartlett C. The value of patient flow charts in reports of randomized controlled trials: bibliographic study. JAMA. 2001;285:1996–9.
Eng J. Sample size estimation: how many individuals should be studied? Radiology. 2003;227:309–13.
Escribano M, Herrera D, Morante S, Teughels W, Quirynen M, Sanz M. Efficacy of a low-concentration chlorhexidine mouth rinse in non-compliant periodontitis patients attending a supportive periodontal care programme: a randomized clinical trial. J Clin Periodontol. 2010;37:266–75.
Esposito M, Coulthard P, Worthington HV, Jokstad A. Quality assessment of randomized controlled trials of oral implants. Int J Oral Maxillofac Implants. 2001;16:783–92.
Fenwick J, Needleman IG, Moles DR. The effect of bias on the magnitude of clinical outcomes in periodontology: a pilot study. J Clin Periodontol. 2008;35:775–82.
Fergusson D, Glass KC, Waring D, Shapiro S. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials. BMJ. 2004;328:432.
Finch C, Braham R, McIntosh A, McCory P, Wolfe R. Should football players wear custom fitted mouthguards? Results from a group randomised controlled trial. Inj Prev. 2005;11:242–6.
Fine D. Periodontal disease in Barnett ML, Pihlstrom BL. Methods for enhancing the efficiency of dental/oral health clinical trials: current status, future possibilities. J Dent Res. 2004;83:744–50.
Fisher CG, Wood KB. Introduction to and techniques of evidence-based medicine. Spine (Phila Pa 1976). 2007;32:S66–72.
Fleiss JL. General design issues in efficacy, equivalency and superiority trials. J Periodont Res. 1992;27:306–13.
Florey CD. Sample size for beginners. BMJ. 1993;306(6886):1181–4.
Forder PM, Gebski VJ, Keech AC. Allocation concealment and blinding: when ignorance is bliss. Med J Aust. 2005;182:87–9.
Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317:141–5.
Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C, CONSORT Group. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med. 2006;144:364–7.
Gansky SA, Ellison JA, Rudy D, Bergert N, Letendre MA, Nelson L, et al. Cluster-randomized controller trial of an athletic trainer-directed spit (smokeless) tobacco intervention for collegiate baseball athletes: results after 1 year. J Athl Train. 2005;40:76–87.
Giraudeau B, Ravaud P, Donner A. Sample size calculation for cluster randomized cross-over trials. Stat Med. 2008;27:5578–85.
GlaxoSmithKline. Clinical Trial Registry. http://www.gsk-clinicalstudyregister.com/. Accessed 11 May 2011.
CONSORT Glossary 2007. Available at http://www.consort-statement.org/resources/glossary/. Accessed 10 May 2011.
Gordon JS, Andrews JA, Lichtenstein E, Severson HH, Akers L. Disseminating a smokeless tobacco cessation intervention model to dental hygienists: a randomized comparison of personalized instruction and self-study methods. Health Psychol. 2005;24:447–55.
Greene WL, Concato J, Feinstein AR. Claims of equivalence in medical research: are they supported by the evidence? Ann Intern Med. 2000;132:715–22.
Greenstein G, Nunn ME. A method to enhance determining the clinical relevance of periodontal research data: number needed to treat (NNT). J Periodontol. 2004;75:620–4.
Grimes DA, Schulz KF. Clinical research in obstetrics and gynecology: a Baedeker for busy clinicians. Obstet Gynecol Surv. 2002;57:S35–53.
Gunsolley JC. Clinical efficacy of antimicrobial mouthrinses. J Dent. 2010;38:S6–10.
Gunsolley JC, Elswick RK, Davenport JM. Equivalence and superiority testing in regeneration clinical trials. J Periodontol. 1998;69:521–7.
Haahr MT, Hróbjartsson A. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors. Clin Trials. 2006;3:360–5.
Harrison JE. Clinical trials in orthodontics II: assessment of the quality of reporting of clinical trials published in three orthodontic journals between 1989 and 1998. J Orthod. 2003;30:309–15.
Hayes RJ, Bennett S. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol. 1999;28:319–26.
Heritier SR, Gebski VJ, Keech AC. Inclusion of patients in clinical trial analysis: the intention-to-treat principle. Med J Aust. 2003;179:438–40.
Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Intervention. http://www.igh.org/Cochrane/tools/Ch16_Specialstatistics.pdf. Accessed 10 May 2011.
Hodges JS. Intention-to-treat has implications for study planning and execution, not just subject retention and follow-up. J Clin Periodontol. 2008;35:683–4.
Hopewell S, Altman DG, Moher D, Schulz KF. Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal ‘Instructions to Authors’. Trials. 2008a;9:20.
Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, et al. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med. 2008b;5:e20.
Hrobjartsson A, Forfang E, Haahr MT, Als-Nielsen B, Brorson S. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding. Int J Epidemiol. 2007;36:654–63.
Hróbjartsson A, Pildal J, Chan AW, Haahr MT, Altman DG, Gøtzsche PC. Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory. J Clin Epidemiol. 2009;62:967–73.
Hugh M, Altman DG, Hammerschlag R, Hammerschlag R, Li YP, Wu TX, White A, Moher D, STRICTA Revision Group. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement (Chinese version). Zhong Xi Yi Jie He Xue Bao. 2010;8:804–18.
Hujoel PP, DeRouen TA. Determination and selection of the optimum number of sites and patients for clinical studies. J Dent Res. 1992;71:1516–21.
International Clinical Trials Registry Platform. http://www.who.int/ictrp/en/. Accessed 11 May 2011.
International Conference on Harmonisation (ICH). Choice of control group in clinical trials, ICH topic E10. London: EMEA; 2000.
Ioannidis JP, Evans SJ, Gotzsche PC, O’Neill RT, Altman DG, Schulz K, et al.; CONSORT Group. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med. 2004;141:781–8.
Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.
James KE, Lee KK, Kraemer HC, Fuller RK. An index for assessing blindness in a multicenter clinical trial: disulfiram for alcohol cessation – a VA cooperative study. Stat Med. 1990;15:1421–34.
Jeffcoat M. What is clinical significance? J Clin Periodontol. 2002;29:S30–2.
Jeffcoat M, Parry S, Sammel M, Clothier B, Catlin A, Macones G. Periodontal infection and preterm birth: successful periodontal therapy reduces the risk of preterm birth. BJOG. 2011;118:250–6.
Jokstad A, Esposito M, Coulthard P, et al. The reporting of randomized controlled trials in prosthodontics. Int J Prosthodont. 2002;15:230–42.
Jönsson B, Ohrn K, Oscarson N, Lindberg P. The effectiveness of an individually tailored oral health educational programme on oral hygiene behaviour in patients with periodontal disease: a blinded randomized-controlled clinical trial (one-year follow-up). J Clin Periodontol. 2009;36:1025–34.
Jönsson B, Ohrn K, Lindberg P, Oscarson N. Evaluation of an individually tailored oral health educational programme on periodontal health. J Clin Periodontol. 2010;37(10):912–9.
Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ. 2001;323:42–6.
Karlsson J, Engebretsen L, Dainty K, ISAKOS Scientific Committee. Considerations on sample size and power calculations in randomized clinical trials. Arthroscopy. 2003;19:997–9.
Kelley K, Maxwell SE, Rausch JR. Obtaining power or obtaining precision. Delineating methods of sample-size planning. Eval Health Prof. 2003;26:258–87.
Kelly PJ, Webster AC, Craig JC. How many patients do we need for a clinical trial? Demystifying sample size calculations. Nephrology (Carlton). 2010;15:725–31.
Kiang H, Bian Z, Tai BJ, Du MQ, Peng B. The effect of a bi-annual professional application of APF foam on dental caries increment in primary teeth: 24-month clinical trial. J Dent Res. 2005;84:265–8.
Kim H-Y, Preisser JS, Rozier RG, Valiyaparambil JV. Multilevel analysis of group-randomized trials with binary outcomes. Community Dent Oral Epidemiol. 2006;34:241–51.
Kingman A. Specific statistical consideration relevant to the design and analysis of gingivitis trials demonstrating product superiority or equivalence. J Periodont Res. 1992;27:378–89.
Kirby A, Gebski V, Keech AC. Determining the sample size in a clinical trial. Med J Aust. 2002;177:256–7.
Koch GG, Paquette DW. Design principles and statistical considerations in periodontal clinical trials. Ann Periodontol. 1997;2:42–63.
Kolahi J, Abrishami M. Multiple-blind: towards a new blinding protocol for future generations of clinical trials. Med Hypotheses. 2009;73:843–5.
Kolahi J, Bang H, Park J. Towards a proposal for assessment of blinding success in clinical trials: up-to-date review. Community Dent Oral Epidemiol. 2009;37:477–84.
Kunz R, Vist G, Oxman AD. Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev. 2007;(2):MR000012.
Lao L, Bergman S, Hamilton GR, Langenberg P, Berman B. Evaluation of acupuncture for pain control after oral surgery: a placebo-controlled trial. Arch Otolaryngol Head Neck Surg. 1999;125:567–72.
LaRosa JC, Applegate W, Crouse 3rd JR, Hunninghake DB, Grimm R, Knopp R, et al. Cholesterol lowering in the elderly. Results of the cholesterol reduction in seniors program (crisp) pilot study. Arch Intern Med. 1994;154:529–39.
Levine RJ, Carpenter WT, Appelbaum PS. Clarifying standards for using placebos. Science. 2003; 300:1659–61.
Lewis JA, Jonsson B, Kreutz G, Sampaio C, van Zwieten-Boot B. Placebo-controlled trials and the Declaration of Helsinki. Lancet. 2002;359(9314):1337–40.
Listgarten MA. General issues in efficacy, equivalency, and superiority trials: clinical considerations. J Periodont Res. 1992;27:314–9.
MacPherson H, Altman DG, Hammerschlag R, Li Y, Wu T, White A, Moher D, STRICTA Revision Group. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. Acupunct Med. 2010a;28:83–93.
MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, Moher D, STRICTA Revision Group. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. J Evid Based Med. 2010b;3:140–55.
Marshman Z, Farid F. The quality of reporting of randomised controlled trials in dental public health. Community Dent Health. 2010;27:253–6.
Masouredis CM, Hilton JF, Grady D, Gee L, Chesney M, Hengl L, et al. A spit tobacco cessation intervention for college athletes: three-month results. Adv Dent Res. 1997;11:354–9.
McAlister FA, Sackett DL. Active-control equivalence trials and antihypertensive agents. Am J Med. 2001; 111:553–8.
McNutt RA, Evans AT, Fletcher RH, Fletcher SW. The effects of blinding on the quality of peer review. JAMA. 1990;263:1371–6.
Meinert CL. Clinical trials, design, conduct and analysis. New York: Oxford University Press; 1985. p. 71–89, 119–37, 288–96.
Michalowicz BS, Hodges JS, DiAngelis AJ, Lupo VR, Novak MJ, Ferguson JE, et al. Treatment of periodontal disease and the risk of preterm birth. N Engl J Med. 2006;355:1885–94.
Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials. 1995;16:62–73.
Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352(9128):609–13.
Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before and after evaluation? JAMA. 2001a;285:1992–5.
Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001b;357(9263):1191–4.
Montenegro R, Needleman I, Moles D, Tonetti M. Quality of RCTs in periodontology – a systematic review. J Dent Res. 2002;81:866–70.
Montori VM, Bhandari M, Devereaux PJ, Manns BJ, Ghali WA, Guyatt GH. In the dark: the reporting of blinding status in randomized controlled trials. J Clin Epidemiol. 2002;55:787–90.
Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, Lacchetti C, Leung TW, Darling E, Bryant DM, Bucher HC, Schünemann HJ, Meade MO, Cook DJ, Erwin PJ, Sood A, Sood R, Lo B, Thompson CA, Zhou Q, Mills E, Guyatt GH. Randomized trials stopped early for benefit: a systematic review. JAMA. 2005;294:2203–9.
Murray DM, Varnell SP, Blistein JL. Design and analysis of group-randomized trials: a review of recent methodological developments. Am J Public Health. 2004;94:423–32.
Neaton JD, Mugglin AS. From observational studies to randomized trials: asking the right question at the right time. J Clin Periodontol. 2006;33:517–9.
Needleman I, Suvan J, Gilthorpe MS, Tucker R, St George G, Giannobile W, Tonetti M, Jarvis M. A randomized-controlled trial of low-dose doxycycline for periodontitis in smokers. J Clin Periodontol. 2007;34:325–33.
Needleman I, Moher D, Altman DG, Schulz KF, Moles DR, Worthington H. Improving the clarity and transparency of reporting health research: a shared obligation and responsibility. J Dent Res. 2008;87:894–5.
Newnham JP, Newnham IA, Ball CM, Wright M, Pennell CE, Swain J, et al. Treatment of periodontal disease during pregnancy: a randomized controlled trial. Obstet Gynecol. 2009;114:1239–48.
Noordzij M, Tripepi G, Dekker FW, Zoccali C, Tanck MW, Jager KJ. Sample size calculations: basic principles and common pitfalls. Nephrol Dial Transplant. 2010;25:1388–93.
Noordzij M, Dekker FW, Zoccali C, Jager KJ. Sample size calculations. Nephron Clin Pract. 2011;118:c319–23.
Odgaard-Jensen J, Vist GE, Timmer A, Kunz R, Akl EA, Schünemann H, Briel M, Nordmann AJ, Pregno S, Oxman AD. Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev. 2011;(4):MR000012.
Pandis N, Polychronopoulou A, Eliades T. An assessment of quality characteristics of randomised control trials published in dental journals. J Dent. 2010;38:713–21.
Park J, Bang H, Cañette I. Blinding in clinical trials, time to do it better. Complement Ther Med. 2008;16:121–3.
Persson GR, Samuelsson E, Lindahl C, Renvert S. Mechanical non-surgical treatment of peri-implantitis: a single-blinded randomized longitudinal clinical study. II. Microbiological results. J Clin Periodontol. 2010;37:563–73.
Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ, CONSORT Group. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA. 2006;295:1152–60.
Pihlstrom BL. Reporting clinical trial results. J Am Dent Assoc. 2009;140:14–5.
Pihlstrom BL, Barnett ML. Design, operation, and interpretation of clinical trials. J Dent Res. 2010;89:759–72.
Pildal J, Hróbjartsson A, Jørgensen KJ, Hilden J, Altman DG, Gøtzsche PC. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol. 2007;36(4):847–57.
Rees JR, Wade TJ, Levy DA, Colford Jr JM, Hilton JF. Changes in beliefs identify unblinding in randomized controlled trials: a method to meet consort guidelines. Contemp Clin Trials. 2005;26:25–37.
Rid A, Schmidt H. The 2008 Declaration of Helsinki – first among equals in research ethics? J Law Med Ethics. 2010;38:143–8.
Scales DC, Rubenfeld GD. Estimating sample size in critical care clinical trials. J Crit Care. 2005;20:6–11.
Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet. 2002a;359(9306):614–8.
Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what. Lancet. 2002b; 359(9307):696–700.
Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance, not choice. Lancet. 2002c;359(9305):515–9.
Schulz KF, Grimes DA. Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet. 2002d;359(9308):781–5.
Schulz KF, Grimes DA. Unequal group sizes in randomised trials: guarding against guessing. Lancet. 2002e;359(9310):966–70.
Schulz KF, Grimes DA. Sample size calculations in randomised trials: mandatory and mystical. Lancet. 2005;365(9467):1348–53.
Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
Simpson JM, Klar N, Donner A. Accounting for cluster randomization: a review of primary prevention trials, 1990 through 1993. Am J Public Health. 1995;85:1378–83.
Sjögren P, Halling A. Quality of reporting randomised clinical trials in dental and medical research. Br Dent J. 2002;192:100–3.
Stoner JA, Payne JB. Interpretation of treatment effects in periodontal research: a note on the number needed to treat. J Can Dent Assoc. 2008;74:435–7.
Turpin DL. CONSORT and QUOROM guidelines for reporting randomized clinical trials and systematic reviews. Am J Orthod Dentofacial Orthop. 2005;128(6):681–5.
Tu YK, Blance A, Clerehugh V, Gilthorpe MS. Statistical power for analyses of changes in randomized controlled trials. J Dent Res. 2005;84:283–7.
Tu Y-K, Maddick I, Kellett M, Clerehugh V, Gilthorpe MS. Evaluating the quality of active-control trials in periodontal research. J Clin Periodontol. 2006;33:151–6.
van der Putten GJ, De Visschere L, Schols J, de Baat C, Vanobbergen J. Supervised versus non-supervised implementation of an oral health care guideline in (residential) care homes: a cluster randomized controlled clinical trial. BMC Oral Health. 2010;10:17.
Van der Weijden F, Slot DE, Rosema M, Timmerman M. ITT in respect to GCP: a matter of diligence. J Clin Periodontol. 2008;35:681–2.
Varela VM, Heller D, Silva-Senem MX, Torres MC, Colombo AP, Feres-Filho EJ. Systemic antimicrobials adjunctive to a repeated mechanical and antiseptic therapy for aggressive periodontitis: a 6-month randomized controlled trial. J Periodontol. 2011;82:1121–30.
Varnell SP, Murray DM, Janega JB, Blitstein JL. Design and analysis of group-randomized trials: a review of recent practices. Am J Public Health. 2004;94:393–9.
Walter SD, Awasthi S, Jeyaseelan L. Pre-trial evaluation of the potential for unblinding in drug trials: a prototype example. Contemp Clin Trials. 2005;26:459–68.
Wei LJ, Lachin JM. Properties of the urn randomization in clinical trials. Control Clin Trials. 1988;9:345–64.
Weingarten MA, Paul M, Leibovici L. Assessing ethics of trials in systematic reviews. BMJ. 2004;328(7446):1013–4.
World Health Organization Website. http://www.who.int/ictrp/data_set/en/index1.html. Accessed 11 May 2011.
Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D, CONSORT Group, Pragmatic Trials in Healthcare (Practihc) Group. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dumitrescu, A.L. (2012). Randomized Controlled Clinical Trials. In: Understanding Periodontal Research. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-28923-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-28923-1_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-28922-4
Online ISBN: 978-3-642-28923-1
eBook Packages: MedicineMedicine (R0)